Search
for
Sort by
Research 481–510 of 1000+
- RNA sequencing reveals lncRNA-mediated non-mendelian inheritance of feather growth change in chickens
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Comprehensive analysis of the expression profiles of mRNA, lncRNA, circRNA, and miRNA in primary hair follicles of coarse sheep fetal skin
- Transcriptomic analysis of regulatory mechanisms in the telogen-anagen transition of ovine hair follicles
- Recent Advances in Genetically Engineered Mouse Models of Melanoma: Insights into Tumor Initiation and Oncogenic Signaling Pathways
- Potential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- JAK inhibitors in dermatology: The promise of a new drug class
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- JAK Inhibitors for Treatment of Alopecia Areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion